Histogenics closes $30.0 million private placement
Histogenics announced closing of its previously disclosed $30.0 million private placement of common stock, Series A Convertible Preferred Stock and warrants. The private placement was led by new healthcare dedicated institutional investors, and existing investors. September 29, 2016